Endocrine Abstracts

Introduction: Gayet-Wernicke encephalopathy (WE) is a rare neurological disorder, caused by thiamine (vitamin B1) deficiency. We report a case of tertiary adrenal insufficiency revealing Gayet-Wernicke encephalopathy.Case presentation: A 45-year-old women was admitted with abdominal pain, vomiting and weakness. Her medical history was significant for a long-term self-medication with corticosteroids and chronic vomiting. Clinical examination revealed a cu...

Introduction: Pheochromocytoma (PHEO) is an adrenal medulla tumor secreting catecholamines. Malignancy is defined by the presence of metastases in non-chromaffin tissue. Its optimal management requires experienced multidisciplinary teams.We report the case of a patient followed for malignant pheochromocytomaComment: 58-year-old patient operated for a pheochromocytoma in 2016, then lost sight of. The evolution was marked 6 years later by the installation ...

Introduction: Brown tumors are osteolytic lesions rarely revealing hyperparathyroidism. They result from abnormalities of bone metabolism. They usually occur in the terminal stage of hyperparathyroidism. We report the case of a patient with hyperparathyroidism revealed by a brown tumor.Case: A 39-year-old female patient with no notable medical history who presented for 1 year a mandibular swelling progressively increasing in size after a dental extractio...

Introduction: Primary hyperparathyroidism (PPH) can be complicated by pancreatitis. The frequency of association of primary hyperparathyroidism with pancreatitis is rare, varying between 1.5% and 7%. We report the case of a patient with hyperparathyroidism revealed by acute pancreatitis.Case: A 78-year-old patient, without any particular history, who consulted the emergency room for an acute digestive picture with abdominal pain and bilious vomiting, an ...

Introduction: Primary hyperparathyroidism is a common pathology. The association of papillary thyroid carcinoma and primary hyperparathyroidism has been reported in 2.3–4.3% of patients operated on for primary hyperparathyroidism.We report the case of a patient with papillary thyroid carcinoma revealed by primary hyperparathyroidismObservation: 53-year-old patient admitted for management of primary hyperparathyroidism. A cervical ultrasound revealed...

Introduction: Lipoatrophy is a rare cutaneous complication in diabetes that presents with localized subcutaneous fat atrophy at the insulin injection site. We report a case of a 62-year-old man type 1 diabetic with lipoatrophy lesions on the thighs.Case report: A 62-year-old male, with clinical history of basedow’s disease, He was diagnosed type 1 diabetes (T1D) when he was 19 years old, treated with premixed human insulin for the last 4 years.His w...

Introduction: Hypertriglyceridemia (HTG) is a rare but well-known cause of acute pancreatitis, which can be fatal with an overall mortality rate of 36-50% in the most severe forms.Case presentation: A 29-year-old patient was admitted to the emergency department with abdominal pain, bilious vomiting and alteration of general condition. Physical examination showed hemodynamic shock with diffuse abdominal tenderness. The Laboratory results showed a serum li...

Introduction: Parkinson’s disease is considered the most common chronic neurodegenerative disease that often affects the elderly, rarely the young. Meanwhile, Diabetes mellitus is the most common chronic metabolic disease. Because of the increase in the prevalence of diabetes and neuro-vegetative diseases, we can wonder about the relationship between the two diseases. We report the case of a patient with type 2 diabetes mellitus associated with young onset Parkinson’...

Introduction: Fournier’s gangrene (FG) is a rare but life-threatening disease. Although originally thought to be an idiopathic process, FG has been shown to have a predilection for patients with diabetes, HIV, alcoholism and other immunocompromised states. We report the case of a patient who presented an inaugural diabetic ketoacidosis revealed by Fournier’s gangreneObservation: A 38-year-old male patient with a smoking history, presented to th...

Introduction: Liraglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist, approved for the treatment of adult patients with type 2 diabetes mellitus of a particular interest in the significant improvement of glycaemic, systolic blood pressure and lipid control with their impact on weight, making it possible to avoid this infernal spiral of weight gain-increased insulin resistance.Observation: 55-year-old female patient, known diabetic for 10 years...